HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SNN
Smith & Nephew plc
There isn't enough reported data to score SNN yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SNN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate SNN's fundamentals.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SNN PE Valuation
SNN has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SNN Forward outlook
There aren't enough analyst estimates for SNN to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SNN Earnings Per Share
SNN and HIMS do not have enough comparable growth data to identify a winner.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SNN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
SNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.1B | +4.6% |
| Q4 2025 | $3.2B | +7.4% |
| Q2 2025 | $3B | +4.7% |
| Q4 2024 | $3B | +6% |
| Q2 2024 | $2.8B | +3.4% |
| Q4 2023 | $2.8B | +7.6% |
| Q2 2023 | $2.7B | +5.2% |
| Q4 2022 | $2.6B | +0.1% |
SNN's revenue has grown year over year for nine quarters in a row: $3.1B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | +2.9 points |
| Q4 2025 | 11% | +6.1 points |
| Q2 2025 | 14% | +4.4 points |
| Q4 2024 | 11% | +3.1 points |
| Q2 2024 | 12% | +2.3 points |
| Q4 2023 | 5.3% | -8.2 points |
| Q2 2023 | 10% | +0.9 points |
| Q4 2022 | 8% | -3.9 points |
SNN has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
SNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $260M | +1.2% |
| Q4 2025 | $595M | +10% |
| Q2 2025 | $257M | +289% |
| Q4 2024 | $540M | +130% |
| Q2 2024 | $66M | +$120M |
| Q4 2023 | $235M | +209% |
| Q2 2023 | -$54M | -259% |
| Q4 2022 | $76M | -73% |
SNN generated $1.7B in free cash flow over the past year, about five times what it generated the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SNN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -6.1M shares |
| 1 year | -1.5% | -6.3M shares |
| 3 years | -51% | -447M shares |
| 5 years | -52% | -466M shares |
| Available history | -52% | -470M shares |
SNN has 430M diluted shares, down 1.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $116M |
| Q4 2025 | $502M |
| Q2 2025 | — |
| Q4 2024 | — |
| Q2 2024 | — |
| Q4 2023 | $1M |
| Q2 2023 | — |
| Q4 2022 | $25M |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SNN Net Leverage
SNN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.1 | Neutral |
| Stochastic | 65.6 | Neutral |
SNN's weekly RSI is 55 (neutral) and its Stochastic is 66 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SNN PE vs Healthcare Sector
| Metric | SNN | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 26x | 26% below |
| PE % | 24 | 29 | 5 pts below |
SNN has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.0 | 6.7% above |
| 20 week MA | $29.4 | 5.4% above |
| 50 week MA | $31.3 | 1% below |
| 100 week MA | $30.9 | 0.4% above |
| 200 week MA | $29.3 | 5.9% above |
SNN has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.5 | $42.1 | -13% |
| 2021 | $42.1 | $34.0 | -19% |
| 2022 | $34.0 | $26.9 | -21% |
| 2023 | $26.9 | $27.3 | +1.5% |
| 2024 | $27.3 | $24.8 | -9.1% |
| 2025 | $24.8 | $33.0 | +33% |
| 2026 YTD | $33.0 | $31.0 | -6.2% |
SNN has the edge over HIMS on returns for 2026, with the stronger performance.